C83.34
Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma, which is a cancer that originates in the lymphatic system. This specific form, coded as C83.34 in the ICD-10 classification, affects the lymph nodes located in the axilla (armpit area) and upper limb. DLBCL is known for its rapid growth and the potential to spread quickly if not treated promptly. Understanding this condition is essential for recognizing the symptoms and seeking appropriate medical attention.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal B-cell growth Immune system deficiencies that impair normal lymphocyte function Infections such as Epstein-Barr virus or Helicobacter pylori Environmental exposures, including certain chemicals or radiation Age-related changes, with higher prevalence among older adults
Key Symptoms: Swollen lymph nodes in the axilla or upper limb area that are often painless Persistent fatigue or weakness Unexplained weight loss Fever that does not go away Night sweats, especially during sleep Itching skin over affected lymph nodes Occasional pain or discomfort in the affected area
Diagnostic & Treatment
Diagnosis Path: Physical Examination: Evaluating swollen lymph nodes and other physical signs. Imaging Tests: Such as CT scans, PET scans, or MRI to assess the size and spread of the lymphoma. Biopsy: Removal of a lymph node or tissue sample for microscopic examination to confirm the presence of cancerous B-cells. Blood Tests: To evaluate overall health status and rule out other conditions. Bone Marrow Biopsy: To check if the disease has spread to the marrow.
Treatment Protocols: Chemotherapy: Often the main treatment, commonly using a regimen called R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone). Immunotherapy: Drugs like Rituximab help the immune system target and destroy lymphoma cells. Radiation Therapy: Used in some cases to target localized lymph nodes. Stem Cell Transplant: Considered for relapsed or resistant cases to restore healthy blood cell production. Targeted Therapy: Medications designed to attack specific molecules involved in cancer growth, used in certain scenarios.
Clinical Advice & FAQs
Billing Guidance
Is C83.34 a billable ICD-10 code?
Yes, C83.34 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.34?
Clinical documentation must specify the nature of Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference